FIELD: medicine, oncology.
SUBSTANCE: in patients with prognostically unfavorable laryngeal and pharyngeal cancer therapy should be started with carrying out chemotherapy with preparations that enhance radiation action. Local hyperthermia should be conducted twice weekly at the background of radiation therapy. Moreover, during hyperthermal days a single focal dosage corresponds to 4 Gy - 2 Gyx2 at 4-h-long interval. The innovation enables to increase efficiency in treating patients with cerebral and cervical squamous cell cancer stage III-IV, improve viability values in this category of patients, decrease toxicity and improve therapeutic results at acceptable increase of topical radiation alterations and hematological toxicity.
EFFECT: higher efficiency of therapy.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF SQUAMOUS CELL P-16 POSITIVE OROPHARYNGEAL CANCER | 2020 |
|
RU2751818C2 |
METHOD OF PERSONALIZED INTRA-ARTERIAL CHEMOTHERAPEUTIC AGENT INFUSION DURING TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK | 2015 |
|
RU2612095C1 |
METHOD OF TREATING LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2020 |
|
RU2739294C1 |
METHOD OF COMBINATION TREATMENT OF OPERABLE NON-SMALL CELL LUNG CANCER STAGE III | 2015 |
|
RU2590866C1 |
METHOD FOR THERMAL CHEMORADIATION OF ADVANCED NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2548770C1 |
METHOD FOR TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2018 |
|
RU2689875C2 |
METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX IN COMBINATION WITH RADIATION AND DRUG EXPOSURE | 2019 |
|
RU2705109C2 |
METHOD OF TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2010 |
|
RU2429032C1 |
METHOD FOR COMBINED TREATMENT OF STAGE III NON-SMALL CELL LUNG CANCER USING THERMOCHEMI-RADIOTHERAPY | 2017 |
|
RU2654612C1 |
METHOD OF COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CANCER OF NASAL CAVITY AND PARANASAL SINUSES WITH USE OF LOCAL HYPERTHERMIA | 2017 |
|
RU2663155C1 |
Authors
Dates
2006-12-20—Published
2005-03-30—Filed